English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduOver the past decade, decreasing vaccination rates now threaten the huge beneficial impacts of vaccinations in the U.S. and globally. Researchers discuss the multifactorial barriers including increasing vaccine hesitancy and new clinical and public health challenges in vaccinations of U.S. adults.
Tag: herd immunity
Needs and Challenges for COVID-19 Boosters and Other Vaccines in the U.S.
FAU researchers and collaborators provide the most updated guidance to health care providers and urge how widespread vaccination with these boosters can now avoid the specter of future and more lethal variants becoming a reality.
Hepatitis A Vaccination Required for Herd Immunity in People Experiencing Homelessness or Who Use Drugs
In the U.S., hepatitis A outbreaks are repeatedly affecting people experiencing homelessness or who use drugs. A 2017-19 Kentucky outbreak primarily among these groups resulted in 501 cases, six deaths. Vaccination efforts likely averted 30 hospitalizations and $490K in costs,…
10 questions you want answered on COVID-19
Should children under the age of 12 be vaccinated against COVID-19? Is it possible to achieve herd immunity? Will an 80 per cent vaccination rate keep us safe? In this video, UniSA epidemiologist Professor Adrian Esterman answers these questions and a lot more. The former World Health Organization consultant shares his expertise – 50 years’ worth – and argues for a different approach to tackling COVID-19.
https://www.youtube.com/watch?v=MLKC9q9yEto
Rush System Nears Zero Patients Hospitalized for COVID-19
Rush system hospitals now have few or no patients with COVID-19 as vaccines’ impact increases.
COVID-19 vaccine: Understanding herd immunity, vaccine hesitancy
Since the beginning of the pandemic, herd immunity has been portrayed as the holy grail to overcome the COVID-19 pandemic.
Rutgers Expert Available to Discuss New US COVID-19 Vaccination Goal, Its Impact on Herd Immunity
Rutgers epidemiologist Stanley H. Weiss is available to discuss the new goal set by President Biden to get 70 percent of American adults vaccinated with at least one dose of a COVID-19 vaccine and having 160 million adults fully vaccinated by July…
Snapshot of COVID-19 Vaccine Intentions Highlights Challenges of Achieving Community Immunity Goals
Ahead of the first U.S. emergency use authorization for a COVID-19 vaccine, only half of Americans said they were likely to get vaccinated as soon as possible.
More than 20% of Texans may have COVID-19 antibodies, serological assessment finds
Four months after launching the nation’s largest COVID-19 serological testing assessment, Texas CARES, researchers at The University of Texas Health Science Center at Houston (UTHealth) and the Texas Department of State Health Services (DSHS) have compiled preliminary data estimating that 14% to 24% of Texans have COVID-19 antibodies.
@DrKatieFoss available for interviews on @POTUS plan to order 100 million more COVID-19 vaccine doses from Johnson & Johnson.
Murfreesboro, TN (March 11, 2021) – Middle Tennessee State University Professor Katherine Foss is available for interviews on President Biden’s plan to order 100 million more COVID-19 doses from Johnson & Johnson. “A one-dose vaccine is really the key to getting the…
COVID-19 VACCINE ACCEPTANCE FALLING GLOBALLY AND IN THE U.S., SURVEY FINDS
The percentage of people globally who say they will get a COVID-19 vaccine has fallen in recent weeks, even as tens of millions of doses have been administered around the world, new survey data suggest.
COVID-19 Vaccine Expert Available: Why You Should Sign up for Your Shot
The images are popping up on our social media feeds: pictures of friends, coworkers, and family members proudly displaying their COVID-19 vaccine card. One might have received Pfizer’s version. Another might have posted a celebratory confirmation of Moderna’s vaccine. It’s…
George Washington University Public Health/Medical Experts Available for Media Interviews on COVID-19 Vaccine
On Dec. 17, a U.S. Food and Drug Administration panel is expected to review the data on the Moderna COVID-19 vaccine, paving the way for approval. Researchers at the George Washington University led one of the 100 clinical sites testing…
Herd immunity an impractical strategy, study finds
Achieving herd immunity to COVID-19 is an impractical public health strategy, according to a new model developed by University of Georgia scientists. The study recently appeared in Proceedings of the National Academy of Sciences.
Story Tips from Johns Hopkins Experts on COVID-19
As COVID-19 continues to impact the world, health care professionals are finding more patients who were diagnosed with the illness but still are dealing with symptoms long after the initial infection has gone. This condition is sometimes referred to as “long COVID.”
Coronavirus antibodies fall dramatically in first 3 months after mild cases of COVID-19
A study by UCLA researchers shows that in people with mild cases of COVID-19, antibodies against SARS-CoV-2 — the virus that causes the disease — drop sharply over the first three months after infection, decreasing by roughly half every 73 days. If sustained at that rate, the antibodies would disappear within about a year.
U.S. cities with pro sports see more flu deaths
Sports leagues may want to consider calling a timeout on reopening their doors to fans, based on new West Virginia University-led research that links an uptick in seasonal flu deaths to U.S. cities with pro sports teams.
UC San Diego Health Launches Novel Coronavirus Blood Testing to Identify Past Exposure
Physicians and scientists at UC San Diego Health have launched a pair of serological tests that will look for novel coronavirus antibodies—evidence in persons tested that they have previously been infected by the viral cause of COVID-19, even if they never experienced tell-tale symptoms.